What is the recommended loperamide (Imodium) dosing regimen for acute non‑bloody, non‑febrile diarrhea in adults and children, including over‑the‑counter and prescription limits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Loperamide Dosing for Acute Non-Bloody, Non-Febrile Diarrhea

For adults and children ≥13 years with acute diarrhea, start with 4 mg (two capsules) immediately, then 2 mg after each unformed stool, not exceeding 16 mg (eight capsules) in 24 hours. 1

Adult Dosing (≥13 Years)

Initial dose: 4 mg (two capsules) followed by 2 mg (one capsule) after each unformed stool 1

Maximum daily dose: 16 mg (eight capsules per day) 2, 1

  • Clinical improvement typically occurs within 48 hours 1
  • Doses should be spaced 1-2 hours apart to allow therapeutic effect and avoid rebound constipation 3
  • Treatment duration for acute diarrhea is generally limited to 48-72 hours 3
  • If symptoms worsen or fail to improve within 48 hours, reassess and consider antibiotics, particularly if fever, bloody diarrhea, or severe abdominal pain develops 3

Pediatric Dosing (Ages 2-12 Years)

Ages 2-5 years (13-20 kg): Use liquid formulation (1 mg/5 mL); give 1 mg three times daily on first day (3 mg total) 1

Ages 6-8 years (20-30 kg): 2 mg twice daily on first day (4 mg total) 1

Ages 8-12 years (>30 kg): 2 mg three times daily on first day (6 mg total) 1

After first day: Give 1 mg per 10 kg body weight only after each loose stool, not exceeding first-day maximum 1

Critical Contraindications

Absolute contraindications:

  • Children under 2 years of age (risk of respiratory depression and cardiac adverse reactions) 1
  • Bloody diarrhea with fever or suspected invasive bacterial infections (Shigella, Salmonella, STEC) 4
  • Severe dysentery with high fever 2, 4

Discontinue immediately if:

  • Bloody diarrhea develops during treatment 3
  • Symptoms worsen after 48 hours 3
  • Signs of paralytic ileus appear 2

Over-the-Counter vs. Prescription Limits

Over-the-counter availability: Loperamide is available without prescription for adults 4

Maximum OTC and prescription dose: Both are limited to 16 mg per day for acute diarrhea 1

  • Higher doses (up to 24 mg/day) have been used in cancer-related chemotherapy-induced diarrhea, but this exceeds FDA-approved dosing and carries increased cardiac risk 5
  • The FDA has warned against exceeding recommended doses due to risk of QT prolongation, torsades de pointes, cardiac arrest, and death 1, 5

Chronic Diarrhea Dosing (If Applicable)

Initial: 4 mg followed by 2 mg after each unformed stool until controlled 1

Maintenance: Average 4-8 mg daily (may be given as single or divided doses) 1

Maximum: 16 mg per day 1

  • If no improvement after 10 days at 16 mg/day, further administration unlikely to help 1
  • Once-daily dosing is often effective for chronic conditions 6

Monitoring and Safety

Patients should:

  • Record number of stools and report fever or dizziness upon standing 3
  • Receive appropriate fluid and electrolyte replacement 1
  • Be monitored for constipation (most common side effect, especially in females) 3

Avoid in elderly patients taking:

  • Class IA or III antiarrhythmics 1
  • Other QT-prolonging medications 1

Practical Considerations

  • Loperamide has minimal systemic absorption and lacks central opiate effects at therapeutic doses 2, 7
  • Superior efficacy compared to diphenoxylate and bismuth subsalicylate 8
  • May be combined with antibiotics for moderate-to-severe traveler's diarrhea when appropriate 3
  • No dose adjustment needed for renal impairment or elderly patients (though elderly require closer cardiac monitoring) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Loperamide Treatment for Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mechanism of Action and Clinical Effects of Lomotil and Loperamide

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2018

Research

Loperamide, a new antidiarrheal agent in the treatment of chronic diarrhea.

Schweizerische medizinische Wochenschrift, 1978

Research

Safety and efficacy of loperamide.

The American journal of medicine, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.